10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
GILEAD SCIENCES, INC. | ||
Ticker: GILD Fiscal Year: 2010 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2010 10-K (Filed: Feb 28, 2011) | ||
| (In Thousands, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2010 | Dec 31, 2009 | |
| Assets | ||
| Cash and cash equivalents | $ 907,879 | 1,272,958 |
| Short-term marketable securities | 1,190,789 | 384,017 |
| Accounts receivable, net of allowances of $150,942 at December 31, 2010 and $132,810 at December 31, 2009 | 1,621,966 | 1,389,534 |
| Inventories | 1,203,809 | 1,051,771 |
| Deferred tax assets | 279,339 | 295,080 |
| Prepaid taxes | 320,424 | 274,196 |
| Prepaid expenses | 67,632 | 78,111 |
| Other current assets | 116,244 | 66,891 |
| Total current assets | 5,708,082 | 4,812,558 |
| Property, plant and equipment, net | 701,235 | 699,970 |
| Noncurrent portion of prepaid royalties | 203,790 | 226,250 |
| Noncurrent deferred tax assets | 153,379 | 101,498 |
| Long-term marketable securities | 3,219,403 | 2,247,871 |
| Intangible assets | 1,425,592 | 1,524,777 |
| Other noncurrent assets | 181,149 | 85,635 |
| Total assets | 11,592,630 | 9,698,559 |
| Liabilities and Stockholders' Equity | ||
| Accounts payable | 803,025 | 810,544 |
| Accrued government rebates | 325,018 | 248,660 |
| Accrued compensation and employee benefits | 147,632 | 132,481 |
| Income taxes payable | 1,862 | 167,623 |
| Other accrued liabilities | 437,893 | 384,015 |
| Deferred revenues | 103,175 | 122,721 |
| Current portion of convertible senior notes, net and other long-term obligations | 646,345 | 5,587 |
| Total current liabilities | 2,464,950 | 1,871,631 |
| Long-term deferred revenues | 32,844 | 43,026 |
| Convertible senior notes, net | 2,838,573 | 1,155,443 |
| Long-term income taxes payable | 107,025 | 87,383 |
| Other long-term obligations | 27,401 | 35,918 |
| Commitments and contingencies (Note 12) | ||
| Stockholders' equity: | ||
| Preferred stock, par value $0.001 per share; 5,000 shares authorized; none outstanding | ||
| Common stock, par value $0.001 per share; 2,800,000 shares authorized; 801,998 and 899,753 shares issued and outstanding at December 31, 2010 and 2009, respectively | 802 | 900 |
| Additional paid-in capital | 4,648,286 | 4,376,651 |
| Accumulated other comprehensive income (loss) | 30,911 | (5,758) |
| Retained earnings | 1,183,730 | 1,995,272 |
| Total Gilead stockholders' equity | 5,863,729 | 6,367,065 |
| Noncontrolling interest | 258,108 | 138,093 |
| Total stockholders' equity | 6,121,837 | 6,505,158 |
| Total liabilities and stockholders' equity | 11,592,630 | 9,698,559 |
| External Links | |
| GILEAD SCIENCES, INC. (GILD) Fiscal Year 2010 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |